Quick Answer
Kalaris Therapeutics, Inc. reported Total Revenue of $165.0 thousand for the year ending 2019.
- This data is from Kalaris Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 12, 2021.
- XBRL data for this metric is available from 2019 to 2019 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: